These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 32936479)

  • 1. Overweight and obesity as protective factors against mortality in nonischemic cardiomyopathy patients with an implantable cardioverter defibrillator.
    Zhou B; Zhao S; Tang M; Chen K; Hua W; Su Y; Chen S; Liang Z; Xu W; Li X; Xue X; Sun X; Zhang S
    Clin Cardiol; 2020 Dec; 43(12):1435-1442. PubMed ID: 32936479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of T wave amplitude in lead aVR on predicting cardiac events in ischemic and nonischemic cardiomyopathy patients with an implantable cardioverter defibrillator.
    Tanaka Y; Konno T; Tamura Y; Tsuda T; Furusho H; Takamura M; Sakata K; Yamagishi M; Hayashi K
    Ann Noninvasive Electrocardiol; 2017 Nov; 22(6):. PubMed ID: 28440568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implantable cardioverter defibrillators for primary prevention in patients with nonischemic cardiomyopathy: A systematic review and meta-analysis.
    Akel T; Lafferty J
    Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28129469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular Magnetic Resonance to Predict Appropriate Implantable Cardioverter Defibrillator Therapy in Ischemic and Nonischemic Cardiomyopathy Patients Using Late Gadolinium Enhancement Border Zone: Comparison of Four Analysis Methods.
    Jablonowski R; Chaudhry U; van der Pals J; Engblom H; Arheden H; Heiberg E; Wu KC; Borgquist R; Carlsson M
    Circ Cardiovasc Imaging; 2017 Sep; 10(9):. PubMed ID: 28838961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [ECG score to predict ICD therapies in patients with nonischemic cardiomyopathy and primary prophylactic CRT-D].
    Grett M; Christ M; Röing Gen Nölke JP; Trappe HJ
    Herzschrittmacherther Elektrophysiol; 2017 Mar; 28(1):48-53. PubMed ID: 28204917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Impact of Implantable Cardioverter-Defibrillator Therapy and Mortality Prediction Model for Effective Primary Prevention in Korean Patients.
    Bae MH; Cho Y; Hwang J; Park HS; Han S; Lee YS; Cho HJ; Jung BC; Lee CH; Hyun DW; Park JS; Ahn J; Kim KH; Shin DG
    J Korean Med Sci; 2020 Mar; 35(9):e49. PubMed ID: 32141247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of the Obesity Paradox With Objective Physical Activity in Patients at High Risk of Sudden Cardiac Death.
    Li X; Chen K; Hua W; Su Y; Yang J; Liang Z; Xu W; Xue X; Zhang S; Zhao S
    J Clin Endocrinol Metab; 2020 Dec; 105(12):. PubMed ID: 32942298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implantable Cardioverter Defibrillators for Primary Prevention of Mortality in Patients With Nonischemic Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials.
    Stavrakis S; Asad Z; Reynolds D
    J Cardiovasc Electrophysiol; 2017 Jun; 28(6):659-665. PubMed ID: 28316104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low body mass index but not obesity is associated with in-hospital adverse events and mortality among implantable cardioverter-defibrillator recipients: insights from the National Cardiovascular Data Registry.
    Hsu JC; Varosy PD; Bao H; Wang Y; Curtis JP; Marcus GM
    J Am Heart Assoc; 2012 Dec; 1(6):e003863. PubMed ID: 23316325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adding the implantable cardioverter-defibrillator to cardiac resynchronization therapy is associated with improved long-term survival in ischaemic, but not in non-ischaemic cardiomyopathy.
    Witt CT; Kronborg MB; Nohr EA; Mortensen PT; Gerdes C; Jensen HK; Nielsen JC
    Europace; 2016 Mar; 18(3):413-9. PubMed ID: 26378089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between mortality and implantable cardioverter-defibrillators by aetiology of heart failure: a propensity-matched analysis of the WARCEF trial.
    Lee TC; Qian M; Mu L; Di Tullio MR; Graham S; Mann DL; Nakanishi K; Teerlink JR; Lip GYH; Freudenberger RS; Sacco RL; Mohr JP; Labovitz AJ; Ponikowski P; Lok DJ; Estol C; Anker SD; Pullicino PM; Buchsbaum R; Levin B; Thompson JLP; Homma S; Ye S;
    ESC Heart Fail; 2019 Apr; 6(2):297-307. PubMed ID: 30816013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence of obesity is associated with lower mortality in elderly patients with implantable cardioverter defibrillator.
    Jahangir A; Mirza M; Shahreyar M; Mengesha T; Shearer R; Sultan S; Jahangir A; Choudhuri I; Nangia V; Dhala A; Bhatia A; Niazi I; Sra J; Tajik AJ
    Int J Obes (Lond); 2018 Feb; 42(2):169-174. PubMed ID: 28852203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcomes after prophylactic ICD and CRT-D implantation in nonischemic patients: Analysis from a nationwide database of daily remote-monitoring transmissions.
    Forleo GB; Solimene F; Pisanò EC; Zanotto G; Calvi V; Pignalberi C; Maglia G; Iacopino S; Quartieri F; Biffi M; Caravati F; Curnis A; Capucci A; Senatore G; Santamaria M; Della Bella P; Manzo M; Giacopelli D; Gargaro A; D'Onofrio A
    J Cardiovasc Electrophysiol; 2019 Sep; 30(9):1626-1635. PubMed ID: 31165517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials.
    Desai AS; Fang JC; Maisel WH; Baughman KL
    JAMA; 2004 Dec; 292(23):2874-9. PubMed ID: 15598919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of gender on mortality or appropriate shock in patients with nonischemic cardiomyopathy who have implantable cardioverter-defibrillators.
    Chen HA; Hsia HH; Vagelos R; Fowler M; Wang P; Al-Ahmad A
    Pacing Clin Electrophysiol; 2007 Mar; 30(3):390-4. PubMed ID: 17367359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of variability in night-time mean heart rate on the prediction of ventricular arrhythmias and all-cause mortality in implantable cardioverter defibrillator patients.
    Zhao S; Chen K; Su Y; Hua W; Pu J; Li H; Dai Y; Tang M; Fan X; Zhao Y; Zheng X; Cai C; Li Z; Zhang S
    Europace; 2015 Oct; 17 Suppl 2():ii76-82. PubMed ID: 26842120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Body Mass Index on Safety and Efficacy of the Subcutaneous Implantable Cardioverter-Defibrillator.
    Frankel DS; Burke MC; Callans DJ; Stivland TM; Duffy E; Epstein AE
    JACC Clin Electrophysiol; 2018 May; 4(5):652-659. PubMed ID: 29798794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy?
    Ellenbogen KA; Levine JH; Berger RD; Daubert JP; Winters SL; Greenstein E; Shalaby A; Schaechter A; Subacius H; Kadish A;
    Circulation; 2006 Feb; 113(6):776-82. PubMed ID: 16461817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Implantable Cardioverter-Defibrillator Therapy in Patients With Nonischemic Cardiomyopathy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Anantha Narayanan M; Vakil K; Reddy YN; Baskaran J; Deshmukh A; Benditt DG; Adabag S
    JACC Clin Electrophysiol; 2017 Sep; 3(9):962-970. PubMed ID: 29759721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of Body Mass Index on Recurrence of Ventricular Arrhythmia, Mortality in Defibrillator Recipients With Ischaemic Cardiomyopathy.
    Samanta R; Narayan A; Pouliopoulos J; Kovoor P; Thiagalingam A
    Heart Lung Circ; 2020 Feb; 29(2):254-261. PubMed ID: 30922553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.